YKYun Jin Kang

Yun Jin Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yun Jin Kang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Se Hwan Hwang

    Department of Otolaryngology‐Head and Neck Surgery Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul South Korea

    15 shared publications
  • Chan-Soon Park

    Department of Otorhinolaryngology-Head and Neck Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    9 shared publications
  • Gulnaz Stybayeva

    Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA

    8 shared publications
  • Do Hyun Kim

    Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

    6 shared publications
  • Gulnaz Stybayeva

    Department of Physiology and Biomedical Engineering Mayo Clinic Rochester Minnesota USA

    5 shared publications
  • Sung Won Kim

    Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea

    5 shared publications

Latest Publications

  • Open Access

    STOP-Bang-Defined Obstructive Sleep Apnea Risk and Organ-Specific Comorbidity Patterns in Korean Adults: A Descriptive Literature-Based Synthesis of KNHANES Studies

    by Yun Jin Kang, Soo Cheol Bang, Juhui Jeong, Chan-Soon Park

    Background and Objective Obstructive sleep apnea (OSA) is prevalent but substantially underdiagnosed; in Korea, most population-based data rely on STOP-Bang screening rather than polysomnography. We investigated whether screening-defined OSA risk correlates with multi-organ disease burden, specifically blood pressure dysregulation, cardiovascular morbidity, renal injury, and ophthalmological vulnerability.Methods A literature-based analysis used seven population-based cross-sectional studies from the Korea National Health and Nutrition Examination Survey (KNHANES, 2019–2021). All studies defined OSA risk using the STOP-Bang questionnaire and reported organ-specific outcomes, including uncontrolled hypertension, cardiovascular morbidity, albuminuria, chronic kidney disease, and glaucoma or intraocular pressure (IOP). Behavioral correlates were also summarized.Results In non-pooled estimates extracted from individual source studies, high STOP-Bang risk was associated with uncontrolled hypertension (adjusted odds ratio [aOR] 1.47; 95% confidence interval [CI] 1.02–2.26) and cardiovascular morbidity (aOR 2.05; 95% CI 1.29–3.24) in adults aged ≥40. Albuminuria was associated with high OSA risk in one model direction (aOR 1.53; 95% CI 1.20–1.95), while high STOP-Bang risk was associated with albuminuria in a separate model direction (aOR 2.51; 95% CI 1.89–3.31). Each one-unit STOP-Bang increase was associated with glaucoma (OR 1.10; 95% CI 1.00–1.20; p=0.044) and higher IOP (β=0.171 mm Hg; 95% CI 0.125–0.218; p<0.001). Former smoking and high-risk alcohol use were independently associated with high-risk OSA status.Conclusions In the Korean general population, screening-defined OSA risk is consistently associated with organ-specific comorbidity patterns across cardiometabolic, renal, and ophthalmological domains. These cross-sectional findings suggest high STOP-Bang risk may serve as a practical marker of cardiometabolic, renal, and ophthalmological vulnerability, rather than indicating a causal disease sequence.

  • Efficacy and Safety of Various Medications in the Treatment of Hereditary Hemorrhagic Telangiectasia Epistaxis

    by Yun Jin Kang, Min Su Kim, Gulnaz Stybayeva, Se Hwan Hwang

    Objectives: To compare the efficacy and safety of pharmacologic therapies for spontaneous epistaxis in hereditary hemorrhagic telangiectasia (HHT). Data Sources: PubMed, Scopus, Embase, Web of Science, and the Cochrane Library were systematically searched up to August 2025. Review Methods: Eligible randomized controlled trials evaluating bevacizumab, doxycycline, tranexamic acid, or β‐blockers versus placebo or standard care were included. Outcomes included epistaxis frequency and duration, hemoglobin (Hb), epistaxis severity score (ESS), transfusion or emergent‐care requirements, quality of life (QOL), and adverse events. Results: Tranexamic acid did not significantly reduce epistaxis duration or frequency or improve Hb, and it did not change transfusion or emergent‐care needs, but it increased diarrhea (odds ratio 3.8, 95% confidence interval [CI] [1.7; 8.5]). Bevacizumab produced a modest reduction in epistaxis frequency (standardized mean difference −0.25, 95% CI [−0.47; −0.02]), without significant effects on duration, ESS, Hb, or QOL. Doxycycline showed no significant benefit for duration or frequency. Topical or systemic β‐blockers did not significantly affect ESS, QOL, Hb, or overall adverse events. Across agents, between‐study heterogeneity was generally low to moderate and CIs were wide, reflecting limited sample sizes. Conclusion: No pharmacologic agent demonstrated consistent, clinically robust superiority over placebo across primary endpoints. Bevacizumab may modestly reduce bleeding burden, whereas tranexamic acid increases gastrointestinal toxicity without clear efficacy. Pharmacologic control of HHT‐related epistaxis remains suboptimal, underscoring the need for adequately powered trials with standardized outcome measures and optimized dosing and delivery strategies.

  • Open Access

    Guideline for the Management of Obesity in Adult Patients With Obstructive Sleep Apnea

    by Soo-Kyoung Park, Yun Jin Kang, Seung Hoon Lee, Chan-Soon Park, Seok Jin Hong, Ji Ho Choi, Jae Hoon Cho

    Objectives. Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder that is strongly influenced by obesity, the most important modifiable risk factor. Effective weight management is therefore essential for optimal OSA care. This guideline provides updated, evidence-based recommendations for the evaluation and management of obesity in adults with OSA, incorporating recent advances in lifestyle, pharmacologic, and surgical interventions.Methods. The Korean Society of Sleep and Breathing convened a multidisciplinary panel. A systematic literature search was performed across major databases through 2025. Evidence was appraised using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, and recommendations were formulated by consensus using the Evidence-to-Decision framework.Results. Eight statements were developed. Key recommendations include recognizing obesity as a major risk factor; routinely assessing overweight and obesity; and implementing structured weight reduction through diet, exercise, and behavioral therapy. Glucagon-like peptide-1 receptor agonists are recommended when lifestyle interventions are insufficient, and bariatric/metabolic surgery is advised for severe obesity unresponsive to nonsurgical treatment. Weight loss improves the apnea-hypopnea index, symptoms, and cardiometabolic markers and may reduce positive airway pressure needs. Continued follow-up is recommended even after clinical improvement.Conclusion. Weight management is a core component of OSA treatment. This guideline offers practical, evidence-based strategies to support clinicians in delivering effective, obesity-focused care for adults with OSA.


  • Open Access

    Effect of Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis

    by Min Su Kim, Gulnaz Stybayeva, Yun Jin Kang, Se Hwan Hwang

    An exhalation delivery system for fluticasone (EDS-FLU) is designed to deposit drug into sinonasal regions above the inferior turbinate, particularly sinus drainage pathways not reached by standard nasal steroid sprays. We evaluated the efficacy and safety of EDS-FLU for chronic rhinosinusitis (CRS). We reviewed four independent randomized controlled trials derived from three published articles identified through searches of PubMed, Embase, SCOPUS, Google Scholar, Web of Science, and the Cochrane Library up to April 2024. Outcomes included 22-item Sinonasal Outcome Test (SNOT-22) scores, nasal symptom scores, nasal polyp scores, patient global impression of change (PGIC), responder and surgical indication rates, and adverse events. Compared with EDS-placebo, EDS-FLU produced greater reductions in nasal polyp scores and SNOT-22 scores over 6 months. At 3 months, nasal congestion, facial pain, rhinorrhea, and olfactory dysfunction improved more with EDS-FLU, and PGIC responder and complete response rates were higher at 3 and 6 months. EDS-FLU reduced surgical indication and increased overall responder rates at 3 months but not at 6 months. Epistaxis and nasal septal erosion or ulceration occurred more frequently with EDS-FLU, whereas rates of headache, nasal congestion, nasopharyngitis, and upper respiratory infection were similar between groups. EDS-FLU provides clinically meaningful improvements in subjective and objective outcomes in CRS but is associated with an increased risk of local nasal adverse events, warranting individualized risk-benefit assessment.

  • Open Access

    Airway Anatomy and Surgical Management in Obstructive Sleep Apnea

    by Yun Jin Kang, Song Tar Toh, Shintaro Chiba, Clement Cheng-Hui Lin, Chan-Soon Park

    Obstructive sleep apnea (OSA) is a sleep-related breathing disorder characterized by recurrent collapse of a structurally vulnerable upper airway during sleep. Airway caliber and stability are influenced by multiple anatomical structures, including the nasal cavity, soft palate, lateral pharyngeal walls, tongue base, hyoid complex, and craniofacial skeleton. Detailed knowledge of these structures is therefore essential for rational surgical planning. This narrative review summarizes key anatomical features relevant to upper pharyngeal surgery, including nasal obstruction and the internal nasal valve, palatal musculature and parapharyngeal fat, and the lateral palatal space as a target for reconstructive palatal and lateral wall procedures. It also outlines lower pharyngeal strategies, such as genioglossus advancement, hyoid myotomy–suspension, and tongue base reduction, which address retroglossal collapse and unfavorable skeletal–soft tissue relationships. Maxillomandibular advancement and hypoglossal nerve stimulation are discussed as anatomy-driven multilevel and neuromodulatory options, respectively. Across these modalities, an anatomically grounded, phenotype-based approach is central to optimizing patient selection, reducing complications, and improving long-term surgical outcomes in OSA.

  • Open Access

    Efficacy and Safety of Fat Graft Myringoplasty Combined With Platelet-Rich Plasma for Managing Chronic Tympanic Membrane Perforations: A Systematic Review and Meta-Analysis

    by Yun Jin Kang, Gulnaz Stybayeva, Se Hwan Hwang

    Objectives: Platelet-rich plasma (PRP) is an autologous product derived from whole blood through the process of gradient density centrifugation. Autologous PRP has been shown to be safe and effective in promoting natural wound healing processes. This study assessed the efficacy of fat graft myringoplasty combined with PRP in tympanic membrane (TM) healing in dry TM perforation due to chronic otitis media and compared it to that of fat graft myringoplasty.Methods: A systematic review and meta-analysis of prospective or retrospective studies was conducted, with database searches (PubMed, Cochrane Library, Embase, Web of Science, Scopus, and Google Scholar) performed through April 2025. The outcomes included the success rate (complete closure of the TM postoperatively) and changes in air-bone conduction gap (ABG) (preoperatively and postoperatively) in the audiogram.Results: Five studies (n=522) were included. Fat myringoplasty with PRP resulted in greater improvement in ABGs (standardized mean difference [SMD], 0.329; 95% CI, 0.132 to 0.527) and higher success rates (odds ratio [OR], 3.129; 95% CI, 1.882 to 5.203) compared to fat myringoplasty alone. In medium-sized perforations, combination therapy demonstrated superior outcomes in both success rate (OR, 3.179; 95% CI, 1.891 to 5.343) and ABG (SMD, 0.357; 95% CI, 0.128 to 0.586). However, no significant differences were observed in cases involving small and medium-sized perforations (success rate: OR, 2.154; 95% CI, 0.174 to 26.672 and changes in ABG: SMD, 0.249; 95% CI, –0.141 to 0.638). Both liquid and gel PRP significantly improved ABGs and TM closure rates, with no significant difference between types.Conclusion: This study demonstrated a higher success rate and greater hearing improvement with PRP-assisted fat myringoplasty, especially in medium-sized perforations. Both liquid and gel PRP forms were effective, with no significant difference between them.


  • Open Access

    Optimizing Human Nasal Turbinate Stem Cell Dosage for the Effective Treatment of Empty Nose Syndrome

    by Yun Jin Kang, Dan Bi Park, David W. Jang, Mi Hyun Lim, Jae Yoon Lee, Seung Yeon Yoo, Sung Won Kim, Do Hyun Kim

    Background and Objectives: Empty nose syndrome (ENS) is a chronic and debilitating condition characterized by atrophic nasal mucosa and impaired mucosal function, resulting in persistent nasal discomfort and breathing difficulties. Despite various surgical and medical interventions, an effective treatment remains elusive. This study investigated the therapeutic potential of a human nasal turbinate stem cell (hNTSC)-based therapeutic agent for ENS.Methods: ENS was induced in a rabbit model via electrocautery, and varying concentrations of hNTSC-based spheroids combined with collagen hydrogel were administered (n=3 per group). Histological and mRNA expression analyses were performed one month posttreatment to assess epithelial thickness and FOXJ1 expression levels.Results: Histological analysis revealed that hNTSC treatment significantly increased epithelial thickness, with the most pronounced effect observed in the medium-dose group (1×107 cells/mL, 50 μL). mRNA analysis showed a dose-dependent increase in FOXJ1 expression, with the highest levels observed in the high-dose group. However, this did not correlate with superior histological recovery, suggesting that epithelial remodeling is optimal at specific cell concentrations.Conclusion: These findings demonstrate that hNTSC-based therapy effectively promotes epithelial regeneration in ENS, with an optimal therapeutic dose identified at 1×107 cells/mL. This study highlights the potential clinical application of stem cell therapy for ENS and underscores the need for precise dose optimization to maximize therapeutic outcomes.


  • Open Access

    Efficacy of Topical Manuka Honey for Chronic Rhinosinusitis After Endoscopic Sinus Surgery: A Systematic Review and Meta-Analysis

    by Yun Jin Kang, Min Ju Kang, Sung Won Kim, Soo Hwan Kim, Yong Jin Park

    Background and Objectives: The aim of this study was to perform a systematic review and meta-analysis evaluating the efficacy of topical manuka honey in the postoperative management of chronic rhinosinusitis following endoscopic sinus surgery.Methods: A systematic search was conducted using PubMed, Embase, OVID, Google Scholar, Web of Science, and the Cochrane Central Register of Controlled Trials. Data were extracted from the randomized trials identified for meta-analysis. Outcome measures—including visual analogue scales, quality of life assessed by the Sinonasal Outcome Test-22, the Philpott-Javer endoscopic score or Lund-Kennedy endoscopic score, post-treatment culture negativity, and adverse effects—were compared between the manuka honey treatment and control groups. Heterogeneity was assessed within subgroups.Results: Four studies including 134 patients were incorporated into the meta-analysis. All subgroup analyses exhibited low heterogeneity. Visual analogue scale scores showed no significant differences, indicating that manuka honey did not cause definite discomfort (standardized mean difference [SMD], -0.46; 95% confidence interval [CI], -1.02 to 0.10). Similarly, improvement in the Sinonasal Outcome Test-22 score was not statistically significant (SMD, -0.03; 95% CI, -0.58 to 0.52). Although the Philpott-Javer score was slightly better in the manuka honey group, the difference was not statistically significant (SMD, 0.13; 95% CI, -0.26 to 0.52), and changes in the Lund-Kennedy endoscopic score from baseline were comparable (SMD, 0.59; 95% CI, -0.03 to 1.21). Culture negativity following manuka honey treatment was marginally improved compared to saline, yet without statistical significance (risk ratio, 0.43; 95% CI, 0.16 to 1.15). No serious adverse effects were reported in any study.Conclusion: Although topical manuka honey appears to have no serious adverse effects, its efficacy should be reconsidered given the lack of statistically significant improvement in sinus mucosal status and post-treatment culture negativity. Further well-designed trials are warranted to clarify its potential benefits.

  • Open Access

    In Reply: Positional Obstructive Sleep Apnea and Periodic Limb Movements During Sleep: A Large Multicenter Study

    by Yun Jin Kang, Chan-Soon Park, Hyun-Woo Shin

    We appreciate the thoughtful comments regarding our study on the relationship between positional obstructive sleep apnea (POSA), OSA severity, and periodic limb movements during sleep (PLMS). In our large multicenter analysis, PLMS prevalence decreased with increasing OSA severity and was significantly higher in patients with POSA, particularly those with severe OSA. While our findings align with previous reports, differences among studies-such as that of Budhiraja et al.- may reflect variation in confounder control, including medication use, which was not captured in our retrospective, anonymized dataset. We acknowledge that iron-related laboratory parameters, including serum ferritin, were not available due to the nature of the dataset. Nonetheless, iron deficiency remains an important consideration in PLMS pathophysiology. Future prospective studies should include detailed clinical, pharmacologic, and laboratory data to clarify these associations. We thank the correspondent for the opportunity to address these important points.

  • Open Access

    Mechanisms and Management of Obstructive Sleep Apnea: A Translational Overview

    by Yun Jin Kang, Chan-Soon Park

    Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of upper airway obstruction during sleep, resulting in apnea and hypopnea. While anatomical factors, such as increased upper airway collapsibility, significantly contribute to OSA, emerging evidence highlights the importance of non-anatomical mechanisms, including impaired pharyngeal muscle responsiveness, low arousal threshold, and elevated ventilatory loop gain. The interplay of these factors leads to respiratory instability, fragmented sleep, and systemic complications. Additional pathophysiological influences such as obesity, aging, sex differences, and central nervous system dysfunction exacerbate cardiovascular and metabolic comorbidities. Advancements in diagnostic methods, including cephalometry and polysomnography, along with therapies such as continuous positive airway pressure, mandibular advancement devices, and hypoglossal nerve stimulation, underscore the necessity for personalized treatment approaches. Although surgical interventions targeting multi-level airway obstructions show potential for successful treatment, they remain limited by variability in long-term efficacy. A thorough understanding of the multifactorial mechanisms underlying OSA is crucial for improving diagnostic accuracy and tailoring patient-specific management strategies. This review summarizes recent findings, clarifying the complex pathophysiology of OSA and highlighting a multidimensional approach to optimize patient outcomes.